Healthcare provider profile · identity verified

Luke Anthony Stephens, M.D.

Sports Medicine · ASHLAND, MO · NPI 1194987461

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	198	42
Lisinopril	Lisinopril	176	41
Levothyroxine Sodium	Levothyroxine Sodium	152	39
Amlodipine Besylate	Amlodipine Besylate	123	28
Omeprazole	Omeprazole	106	28
Hydrochlorothiazide	Hydrochlorothiazide	92	26
Gabapentin	Gabapentin	90	31
Losartan Potassium	Losartan Potassium	74	21
Zolpidem Tartrate	Zolpidem Tartrate	73	14
Tramadol Hcl	Tramadol Hcl	70	13
Sertraline Hcl	Sertraline Hcl	68	13
Metformin Hcl	Metformin Hcl	67	18
Pantoprazole Sodium	Pantoprazole Sodium	65	18
Rosuvastatin Calcium	Rosuvastatin Calcium	63	20
Furosemide	Furosemide	60	13
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	59	17
Tamsulosin Hcl	Tamsulosin Hcl	58	17
Clonazepam	Clonazepam	55	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	54	15
Clopidogrel	Clopidogrel Bisulfate	51	12
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	51	suppressed
Fluticasone Propionate	Fluticasone Propionate	50	15
Carvedilol	Carvedilol	45	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	45	suppressed
Metoprolol Succinate	Metoprolol Succinate	45	13
Potassium Chloride	Potassium Chloride	44	suppressed
Simvastatin	Simvastatin	44	12
Montelukast Sodium	Montelukast Sodium	43	suppressed
Pregabalin	Pregabalin	43	suppressed
Trazodone Hcl	Trazodone Hcl	42	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	38	suppressed
Duloxetine Hcl	Duloxetine Hcl	36	suppressed
Alprazolam	Alprazolam	35	suppressed
Finasteride	Finasteride	35	suppressed
Eliquis	Apixaban	34	suppressed
Oxycodone Hcl	Oxycodone Hcl	34	suppressed
Lorazepam	Lorazepam	33	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	32	11
Tizanidine Hcl	Tizanidine Hcl	31	suppressed
Citalopram Hbr	Citalopram Hydrobromide	30	suppressed
Glipizide	Glipizide	30	suppressed
Mirtazapine	Mirtazapine	28	suppressed
Levetiracetam	Levetiracetam	26	suppressed
Morphine Sulfate Er	Morphine Sulfate	26	suppressed
Pravastatin Sodium	Pravastatin Sodium	26	suppressed
Prednisone	Prednisone	26	13
Jardiance	Empagliflozin	21	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	21	suppressed
Metformin Hcl Er	Metformin Hcl	21	suppressed
Allopurinol	Allopurinol	20	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	19	suppressed
Propranolol Hcl	Propranolol Hcl	19	suppressed
Diclofenac Sodium	Diclofenac Sodium	18	suppressed
Symbicort	Budesonide/Formoterol Fumarate	18	suppressed
Flecainide Acetate	Flecainide Acetate	17	suppressed
Methadone Hcl	Methadone Hcl	17	suppressed
Mounjaro	Tirzepatide	17	suppressed
Bupropion Hcl Sr	Bupropion Hcl	16	suppressed
Bupropion Xl	Bupropion Hcl	16	suppressed
Farxiga	Dapagliflozin Propanediol	16	suppressed
Lovastatin	Lovastatin	16	suppressed
Methocarbamol	Methocarbamol	16	suppressed
Gemfibrozil	Gemfibrozil	15	suppressed
Celecoxib	Celecoxib	14	suppressed
Glipizide Er	Glipizide	14	suppressed
Linzess	Linaclotide	14	suppressed
Ondansetron Hcl	Ondansetron Hcl	14	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	13	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	13	suppressed
Baclofen	Baclofen	13	suppressed
Creon	Lipase/Protease/Amylase	13	suppressed
Diazepam	Diazepam	13	suppressed
Hydralazine Hcl	Hydralazine Hcl	13	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	13	suppressed
Paroxetine Hcl	Paroxetine Hcl	13	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	13	suppressed
Rybelsus	Semaglutide	13	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	13	suppressed
Breo Ellipta	Fluticasone/Vilanterol	12	suppressed
Chlorthalidone	Chlorthalidone	12	suppressed
Ondansetron Odt	Ondansetron	12	suppressed
Spiriva Respimat	Tiotropium Bromide	12	suppressed
Xarelto	Rivaroxaban	12	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	11	suppressed
Atenolol	Atenolol	11	suppressed
Warfarin Sodium	Warfarin Sodium	11	suppressed
Zenpep	Lipase/Protease/Amylase	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error